![]() |
市場調查報告書
商品編碼
1959988
醫用皮膚黏合劑市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、產品、最終用戶、地區和競爭格局分類,2021-2031年Medical Stick-to-Skin Adhesives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End User, By Region & Competition, 2021-2031F |
||||||
全球醫用皮膚黏合劑市場預計將從 2025 年的 28.3 億美元成長到 2031 年的 44.5 億美元,複合年成長率為 7.84%。
這些黏合劑是專門設計的生物相容性黏合劑,用於將穿戴式感測器、傷口敷料、醫療設備和其他組件牢固、長期地固定在皮膚上。市場成長的主要驅動力是心血管疾病和糖尿病等慢性疾病的日益普遍,這些疾病需要頻繁的創傷護理和持續監測。全球人口老化也進一步強化了這一成長趨勢,因為老化需要持續的醫療支援。根據國際糖尿病聯盟的數據,到2024年,全球將有約5.89億成年人患有糖尿病,凸顯了依賴黏合劑的解決方案(例如潰瘍敷料和血糖監測儀)的重要性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 28.3億美元 |
| 市場規模:2031年 | 44.5億美元 |
| 複合年成長率:2026-2031年 | 7.84% |
| 成長最快的細分市場 | 丙烯酸纖維 |
| 最大的市場 | 北美洲 |
然而,阻礙市場擴張的一大挑戰是醫用黏合劑相關皮膚損傷(MARSI)的發生。製造商難以平衡強力黏合與溫和非侵入性移除的要求,尤其是在皮膚脆弱的老年患者。這構成了一項技術障礙,可能會限制產品在敏感臨床應用中的使用。
穿戴式醫療設備和遠端患者監護的日益普及正在從根本上改變全球醫用皮膚黏合劑市場,製造商優先研發生物相容性配方,以確保感測器能夠長時間牢固固定。這一趨勢在持續血糖監測 (CGM) 系統的快速發展中尤其明顯,這類系統需要使用不易脫落且能在各種環境條件下保持皮膚完整性的黏合劑。主要設備製造商的財務表現也反映了這些依賴黏合劑技術的激增。根據 Dexcom 於 2025 年 10 月發布的 2025 年第三季財報,其全球營收年增 22% 至 12.09 億美元,凸顯了黏合劑貼片對於滿足不斷成長的用戶群的重要性。此外,對貼片式給藥系統的廣泛需求也推動了這一趨勢。根據 Inslet 於 2025 年 11 月發布的 2025 年第三季財報,其依賴黏合劑的無管胰島素幫浦技術帶來的總收入達到 7.063 億美元。
同時,先進創傷護理和外科敷料市場的成長成為第二個促進因素,市場對既能牢固固定又能無痛移除的黏合劑的需求日益成長,尤其適用於脆弱的皮膚。隨著慢性疾病和人口老化推動了對先進傷口管理的需求,泡沫敷料和皮膚替代物的消費量正在加速成長,黏合劑的創新也正朝著保濕和低過敏性解決方案的方向發展。這一細分市場的擴張也反映在近期的行業趨勢。根據史密斯醫療(Smith+Nephew)於2025年11月發布的《2025年第三季交易報告》,其先進傷口護理業務部門實現了6.0%的收入成長,這反映出臨床上對高性能粘合敷料在有效促進患者康復方面的持續依賴。
全球醫用皮膚黏合劑市場擴張面臨的主要挑戰是醫用黏合劑相關皮膚損傷(MARSI)的高發生率。製造商面臨一個複雜的技術難題:他們必須開發出既能為大型裝置提供牢固持久黏合,又能確保非侵入性移除的產品。要實現這一平衡並非易事,因為強力黏合劑在移除時往往會導致皮膚完整性受損的患者出現皮膚剝落或撕裂。因此,醫療專業人員通常不願意為脆弱的病患小組採用基於黏合劑的監測解決方案,這在對皮膚安全性要求極高的臨床環境中構成了市場滲透的重大障礙。
由於易受黏合劑相關皮膚損傷影響的人群正在迅速成長,這項技術限制構成了一個嚴重的障礙。無法保證皮膚安全阻礙了市場充分利用老年護理產品日益成長的需求。根據人口參考局預測,到2024年,全球10%的人口將達到或超過65歲。鑑於大量患者天生皮膚脆弱,醫用黏合劑相關皮膚損傷(MARSI)的風險顯然限制了市場規模。製造商正努力為這一不斷成長的高風險族群開發安全的黏合劑。
生物分解和生物基材料的開發正在迅速改變醫用皮膚黏合劑的化學成分。這主要是由於該行業迫切需要減少對石油的依賴以及範圍3排放。製造商正積極用可堆肥和可再生資源衍生的替代品取代傳統的丙烯酸和合成橡膠配方,以最大限度地減少對環境的影響,同時保持臨床等級的黏性。這種轉變在技術上極具挑戰性,因為生物聚合物必須在患者使用過程中能夠耐受水分和細菌滋生,並在處置後高效分解。由於近期材料創新,這些永續方案的商業性可行性正變得越來越清晰。根據2025年11月《黏合劑雜誌》(Adhesives Magazine)報導「壓敏黏著劑下一代高科技製造」的文章,漢高公司開發了生物基含量高達70%的「TECHNOMELT DM ECO」配方,在不影響黏合劑耐久性的前提下,為降低黏合劑產品的碳棒樹立了新的標竿。
智慧型感測器整合黏合劑的出現,正將被動固定劑轉變為能夠即時進行傷口管理的診斷工具。傳統的OK繃黏合劑只能將傷口固定到位,而這些先進的系統則融合了生物電子技術和刺激應答型高分子,能夠檢測感染標記(例如pH值變化),並自主觸發治療性介入。這種整合創造了封閉回路型癒合環境,其中黏合劑層本身不再只是機械固定裝置,而是直接參與加速組織恢復。檢驗這些系統有效性的研究凸顯了它們革新慢性創傷護理的潛力。根據2025年9月發表在ScienceDaily上的一篇題為「人工智慧驅動的智慧繃帶創傷治療25%」的報告,新型封閉回路型黏合劑裝置的臨床前試驗表明,與標準治療相比,癒合速度提高了約25%,這表明能夠積極參與生理癒合過程的黏合劑具有巨大的市場潛力。
The Global Medical Stick-to-Skin Adhesives Market is projected to expand from a valuation of USD 2.83 Billion in 2025 to USD 4.45 Billion by 2031, reflecting a CAGR of 7.84%. These adhesives function as specialized, biocompatible bonding agents designed to securely attach wearable sensors, wound dressings, and medical devices to the epidermis for prolonged durations. The market's growth is primarily fueled by the increasing incidence of chronic conditions, such as cardiovascular diseases and diabetes, which necessitate frequent wound care and continuous monitoring. This upward trajectory is further bolstered by an aging global demographic that requires sustained medical assistance. Data from the International Diabetes Federation indicates that approximately 589 million adults worldwide were living with diabetes in 2024, underscoring the critical need for adhesive-dependent solutions like ulcer dressings and glucose monitors.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.83 Billion |
| Market Size 2031 | USD 4.45 Billion |
| CAGR 2026-2031 | 7.84% |
| Fastest Growing Segment | Acrylic-Based |
| Largest Market | North America |
However, a significant challenge impeding market expansion is the prevalence of Medical Adhesive-Related Skin Injury (MARSI). Manufacturers struggle to balance the need for robust adhesion with the requirement for gentle, trauma-free removal, particularly for elderly patients with fragile skin, creating a technical barrier that can limit product adoption in sensitive clinical applications.
Market Driver
Rising adoption of wearable medical devices and remote patient monitoring is fundamentally reshaping the Global Medical Stick-to-Skin Adhesives Market, as manufacturers prioritize biocompatible formulations capable of securing sensors for extended durations. This trend is exemplified by the rapid expansion of continuous glucose monitoring (CGM) systems, which require adhesives that maintain skin integrity under varying environmental conditions without detaching. The surge in utilization of these adhesive-reliant technologies is evident in the financial performance of major device manufacturers. According to Dexcom, October 2025, in the 'Third Quarter 2025 Financial Results', worldwide revenue grew 22% year-over-year to $1.209 billion, underscoring the critical volume of adhesive patches required to support this expanding user base. Furthermore, the broader demand for patch-based delivery systems reinforces this trajectory; according to Insulet, November 2025, in the 'Third Quarter 2025 Results', total revenue reached $706.3 million, driven by the adoption of their adhesive-dependent tubeless insulin pump technology.
Concurrently, growth in the advanced wound care and surgical dressings market acts as a secondary powerhouse, necessitating adhesives that balance strong fixation with atraumatic removal for fragile skin. As chronic conditions and an aging demographic drive the need for sophisticated wound management, the consumption of foam dressings and skin substitutes has accelerated, pushing adhesive innovation toward moisture-managing and hypoallergenic solutions. This segment's expansion is quantitatively visible in recent industry updates. According to Smith+Nephew, November 2025, in the 'Third Quarter 2025 Trading Report', the Advanced Wound Management business unit delivered revenue growth of 6.0%, reflecting the sustained clinical reliance on high-performance adhesive dressings for effective patient recovery.
Market Challenge
The primary challenge impeding the expansion of the Global Medical Stick-to-Skin Adhesives Market is the prevalence of Medical Adhesive-Related Skin Injury (MARSI). Manufacturers face a complex technical contradiction where they must engineer products that offer robust, long-term adhesion for heavy wearable devices while simultaneously ensuring atraumatic removal. This balance is difficult to achieve for patients with compromised skin integrity, as strong bonding agents often cause skin stripping or tearing upon detachment. Consequently, healthcare providers frequently hesitate to adopt adhesive-based monitoring solutions for vulnerable patient groups, creating a significant barrier to market penetration in clinical settings that require superior skin safety.
This technical limitation acts as a severe constraint because the demographic most susceptible to adhesive injury is expanding rapidly. The inability to guarantee skin safety prevents the market from fully capitalizing on the growing demand for geriatric care products. According to the Population Reference Bureau, in 2024, 10% of the global population was aged 65 and older. This substantial volume of patients with naturally fragile skin highlights how the risk of MARSI directly limits the addressable market, as manufacturers struggle to produce adhesives that are safe for this widening high-risk category.
Market Trends
The development of biodegradable and bio-based materials is rapidly altering the chemical composition of medical stick-to-skin adhesives, driven by the industry's urgent need to reduce petroleum reliance and Scope 3 emissions. Manufacturers are actively replacing traditional acrylic and synthetic rubber formulations with compostable, renewably sourced alternatives that maintain clinical-grade tackiness while minimizing environmental impact. This shift is technically demanding, as bio-polymers must resist moisture and bacterial growth during patient use, yet break down efficiently post-disposal. The commercial viability of these sustainable options is increasingly evident in recent material innovations. According to Adhesives Magazine, November 2025, in the article 'Pressure-Sensitive Adhesives Enable the Next Wave of High-Tech Manufacturing', Henkel introduced the TECHNOMELT DM ECO formulation which delivers 70% bio-based content, establishing a new benchmark for reducing the carbon footprint of adhesive products without compromising bonding durability.
The emergence of smart and sensor-integrated adhesives is transforming passive fixing agents into active diagnostic tools capable of real-time wound management. Unlike standard adhesives that simply secure a dressing, these advanced systems incorporate bioelectronics and stimuli-responsive polymers to detect infection markers, such as pH changes, and autonomously trigger therapeutic interventions. This integration creates closed-loop healing environments where the adhesive layer itself plays a direct role in accelerating tissue recovery rather than serving solely as a mechanical fastener. Research validating the efficacy of these systems highlights their potential to revolutionize chronic wound care. According to ScienceDaily, September 2025, in the report 'AI-powered smart bandage heals wounds 25% faster', preclinical tests of a new closed-loop adhesive device demonstrated a healing trajectory approximately 25% faster than standard care, validating the market potential for adhesives that actively participate in the physiological healing process.
Report Scope
In this report, the Global Medical Stick-to-Skin Adhesives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Medical Stick-to-Skin Adhesives Market.
Global Medical Stick-to-Skin Adhesives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: